A global research priority agenda to advance public health responses to fatty liver diseasePatrizia Burra, Alina M. Allen, C Wendy Spearman et al.|Journal of Hepatology|2023Cited by 132
A global action agenda for turning the tide on fatty liver diseaseJeffrey V. Lazarus, Saleh A. Alqahtani, Emmanuel Tsochatzis et al.|Hepatology|2023Cited by 90
Opportunities and challenges following approval of resmetirom for MASH liver diseaseJeffrey V. Lazarus, Paul Brennan, Meena B. Bansal et al.|Nature Medicine|2024Cited by 57
A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver diseaseDana Ivancovsky‐Wajcman, Jeffrey V. Lazarus, John Dillon et al.|Hepatology|2024Cited by 29